The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain (R01 Clinical Trial Not Allowed)
This funding opportunity announcement (FOA) invites research to develop, characterize, and rigorously validate non-rodent mammalian models of pain, associated outcome measures and/or endpoints that will significantly advance translational research for effective pain management. These models are expected to recapitulate molecular, cellular, pathological, behavioral, and/or cognitive aspects of human pain disorders and conditions. Research supported under this FOA is expected to provide well-validated models and measures that facilitate the development of non-opioid analgesic therapeutic interventions with little or no addiction liability.
Letter of Intent Due Date(s): 30 days prior to the application due date.
Application Due Dates: Nov 4, 2022; March 7, 2023; July 6, 2023; Nov 7, 2023; March 6, 2024
RFA-NS-22-070 Expiration Date March 07, 2024
Application budgets need to reflect the actual needs of the proposed project and are limited to direct costs of $750,000 per year.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.